Acquisition Growth Medisolv has expanded through multiple acquisitions in 2026, including Health Elements AI and Lilac Software, signaling a strategy to enhance data capture, AI capabilities, and value-based care offerings. This presents a sales opportunity to position advanced data integration, AI-driven analytics, and interoperability solutions to support post-merger integration and scale.

Quality Data Focus The company markets itself as harnessing quality data to improve patient care and provider performance. This creates demand for comprehensive quality measurement, clinical registries, and automated reporting capabilities to bolster hospital quality programs and regulatory reporting.

Healthcare Market Position Medisolv is trusted by over 1,800 healthcare organizations and 100,000+ providers, with recognition from Best in KLAS, Black Book, and HIMSS Policy Changemaker awards. Use this credibility to co-sell solutions that integrate with large health systems and expand market reach.

Regulatory & AI Synergy Recent strategic moves emphasize eCQM data capture, AI capabilities, and compliance with HIPAA. This alignment creates opportunities to offer AI-assisted quality reporting, automated data structuring from EHRs, and compliant analytics platforms for value-based care programs.

Growth Signals Revenue range suggests mid-market to enterprise focus with potential upsell to expansive hospital networks and health systems. Leverage advisory services and data modernization offerings to deepen contracts and expand adoption across facilities and departments.